Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting Report

Extent of immunohistochemical PSMA-expression in primary prostate cancer shows a high correlation with tumor uptake on 68Ga-PSMA-11-PET.

Irene Burger, Jan Ruschoff, Thomas Hermanns, Daniel Eberli and Niels Rupp
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1263;
Irene Burger
1University Hospital Zurich Zurich Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Ruschoff
1University Hospital Zurich Zurich Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Hermanns
1University Hospital Zurich Zurich Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Eberli
1University Hospital Zurich Zurich Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niels Rupp
1University Hospital Zurich Zurich Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1263

Objectives: Limited data exist regarding the exact histopathological correlation between PSMA protein expression, tumor heterogeneity and functional uptake of 68Ga-PSMA-11 on PET. Aim of this study was, to identify immunohistochemical (IHC) PSMA patterns on radical prostatectomy specimens and correlate them to corresponding 68Ga-PSMA-PET examinations.

Methods: Retrospective, single center analysis of patients that underwent 68Ga-PSMA-11-PET and consecutive radical prostatectomy between 2016-2018 for prostate cancer (PCa). The dominant tumor lesion was identified and stained by IHC for PSMA. Maximal tumor diameter, Gleason Score (GS), PSMA expression on a semi-quantitative 4-tiered system and percentage of expressing tumor cells (PSMA%pos) were noted. Pathology specimens were correlated in an interdisciplinary read out with PSMA PET images and 68Ga-PSMA-11 uptake was quantified using SUVmax in the selected tumor area. Correlation between histopathological parameters and SUVmax was assessed using Spearman correlation.

Results: 37 patients were available for this analysis. PSMA%pos and SUVmax had a significant correlation (r=0.715, p<0.001), while IHC intensity grading did not reach significance (r=0.193, p=0.252). The mean SUVmax in lesions with PSMA%pos ≤ 60% was 3.7 (SD 0.6, range 3.1-4.8), lesions with PSMA%pos > 60% had a mean SUVmax of 14.9 (SD 11.5, range 3.5-48.4). All lesions (n=5) with a SUVmax below 5 and PSMA%pos > 60% had a very heterogeneous and infiltrative growth pattern and two were smaller than 4 mm in diameter on histopathology. 25% of GS 7a lesions had PSMA%pos ≤60%, compared to 17% GS 7b and 11% GS≥8, respectively. Limitations include retrospective design and the low number of specimens.

Conclusions: PSMA-positive tumor area showed a strong correlation with SUVmax while PSMA intensity on IHC did not reach significance. Furthermore, our data confirms a higher rate of dominantly PSMA%pos tumors at higher GS.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Extent of immunohistochemical PSMA-expression in primary prostate cancer shows a high correlation with tumor uptake on 68Ga-PSMA-11-PET.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Extent of immunohistochemical PSMA-expression in primary prostate cancer shows a high correlation with tumor uptake on 68Ga-PSMA-11-PET.
Irene Burger, Jan Ruschoff, Thomas Hermanns, Daniel Eberli, Niels Rupp
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1263;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Extent of immunohistochemical PSMA-expression in primary prostate cancer shows a high correlation with tumor uptake on 68Ga-PSMA-11-PET.
Irene Burger, Jan Ruschoff, Thomas Hermanns, Daniel Eberli, Niels Rupp
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1263;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Rest Dose Spillover Correction of Stress Blood Flow Measurements in Digital Rb-82 Myocardial Perfusion PET/CT Imaging
  • Radiolabeled hyaluronic acid (HA) fragments for lymphatic imaging
  • Simplifying and Confirming Ketosis: A Quality Improvement Initiative in Cardiac Sarcoid Assessment
Show more

GU - PSMA PET (Poster Session)

  • 18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine-kinase and check-point inhibitor therapy - preliminary results
  • Dynamic 18F-DCFPyL PET/CT imaging of biopsy-proven high-risk primary prostate cancer patients
Show more GU - PSMA PET (Poster Session)

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire